13.35
0.00
(0.00%)
At close: February 25 at 1:19:14 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 2 | 4 | 4 |
| Avg. Estimate | 300k | -- | 3.62M | -- |
| Low Estimate | -- | -- | 3.29M | -- |
| High Estimate | 1.2M | -- | 4.6M | -- |
| Year Ago Sales | 1.42M | 1.01M | 6.04M | 3.62M |
| Sales Growth (year/est) | -78.86% | -100.00% | -40.02% | -100.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OCGN.MX | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
| Maintains | Chardan Capital: Buy to Buy | 2/13/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/13/2025 |
| Maintains | Chardan Capital: Buy to Buy | 1/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/13/2025 |
| Maintains | Chardan Capital: Buy to Buy | 11/18/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
Related Tickers
INO.MX Inovio Pharmaceuticals, Inc.
40.00
0.00%
ATOS.MX Atossa Therapeutics, Inc.
14.70
-8.13%
NRSNW NeuroSense Therapeutics Ltd.
0.1531
-23.45%
MRNA.MX Moderna, Inc.
624.80
+0.29%
ENTO Entero Therapeutics, Inc.
0.6100
+23.31%
NRSN NeuroSense Therapeutics Ltd.
1.0500
-4.11%
ITRM Iterum Therapeutics plc
1.3300
-4.66%
ATOS Atossa Therapeutics, Inc.
0.7410
-3.23%
SLS SELLAS Life Sciences Group, Inc.
1.1600
-1.69%
INO Inovio Pharmaceuticals, Inc.
1.8400
-7.07%